Fibrilación auricular y cardiopatía isquémica: más allá de la prevención del ictus

Alegría Ezquerra, Eduardo; Agra Bermejo, Rosa; Alonso Perez, Luis Javier; Fernández Fernández, Miguel Ángel; Vázquez Rodríguez, Jose Manuel; Díaz Castro, Óscar; Bravo Amaro, Marisol; Ríos Vázquez, Ramón; Martí-Almor, Julio.
Rev. esp. cardiol. Supl. (Ed. impresa) ; 20(supl.A): 11-20, ene. 2020. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-197027

Documentos relacionados

  1. Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials.
  2. Prime Time for a Trial Assessing Safety of Intravenous Thrombolysis in Patients Treated With Direct Oral Anticoagulants.
  3. Enoxaparin Dosing at Extremes of Weight: Literature Review and Dosing Recommendations.
  4. Antithrombotic therapy for chronic coronary syndrome and atrial fibrillation: less might be more.
  5. Advances in Nano-Functional Materials in Targeted Thrombolytic Drug Delivery.
  6. Ischaemic stroke and transient ischaemic attack on anticoagulants: outcomes in the era of direct oral anticoagulants.
  7. Secondary Prevention with Antithrombotic Therapies in Stable Ischemic Heart Disease Patients: a Review.
  8. In ischemic stroke, adding IV thrombolysis ≤2 h after symptom onset to thrombectomy was associated with benefit.
  9. Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis.
  10. [Therapeutic effect of intravenous thrombolysis with tenecteplase on patients with post awakening branch atheromatous disease].